Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral AI Inc MDAI

Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential... see more

Recent & Breaking News (NDAQ:MDAI)

Spectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call

GlobeNewswire March 13, 2024

Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of DeepView(TM) Wound Imaging System

GlobeNewswire March 12, 2024

Spectral AI Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem

GlobeNewswire March 7, 2024

Spectral AI Appoints Peter M. Carlson as CEO

GlobeNewswire February 29, 2024

Spectral AI to Participate in Upcoming Investor Conferences

GlobeNewswire February 28, 2024

Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024

GlobeNewswire February 22, 2024

Spectral AI Appoints Dr. J. Michael DiMaio to Board of Directors

GlobeNewswire February 12, 2024

Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire February 6, 2024

Spectral AI Announces Publication of Letter to Shareholders

GlobeNewswire February 5, 2024

Spectral Submits Application for UKCA Mark Classification

GlobeNewswire January 29, 2024

Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion?

PR Newswire January 29, 2024

Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries

GlobeNewswire January 11, 2024

Spectral AI Names Industry Veteran and Former Top MiMedx Financial Executive Peter M. Carlson as CFO

GlobeNewswire December 19, 2023

Spectral AI to Participate in Benchmark's 12th Annual Discovery One-on-One Conference

GlobeNewswire November 30, 2023

Spectral AI Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors

GlobeNewswire November 27, 2023

Spectral AI Announces 2023 Third Quarter Financial Results

GlobeNewswire November 13, 2023

Spectral AI Schedules 2023 Third Quarter Financial Results and Conference Call

GlobeNewswire November 1, 2023

Spectral AI names Prof. Paul Chadwick, Former CEO of the Royal College of Podiatry UK, as Senior Executive for UK and EMEA

GlobeNewswire October 24, 2023

Spectral AI Provides 2023-2024 Annual Revenue Guidance

GlobeNewswire October 23, 2023

Spectral AI's DeepView SnapShot® Wound Imaging System, Achieves UKCA Mark and FDA Class 1 Medical Device Classification

GlobeNewswire October 19, 2023